國家衛生研究院 NHRI:Item 3990099045/5523

NHRI > National Institute of Infectious Diseases and Vaccinology > Chi-Jung Wu > Periodical Articles > Item 3990099045/5523

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5523

Title:	Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan
Authors:	Huang, CC;Wu, CJ;Wang, LR;Lee, HC;Chang, CM;Lee, NY;Chen, TY;Ko, WC
Contributors:	Division of Infectious Diseases
Abstract:	Background: Few studies focus on comparison of antimicrobial susceptibility for bacteremic isolates in neutropenic and nonneutropenic cancer patients. The purpose of this study was to elucidate the antimicrobial susceptibility of bacteremic isolates from cancer patients. Methods: We collected bacterial isolates causing bloodstream infections in cancer patients at a tertiary care hospital from 2003 to 2005 and performed in vitro antimicrobial susceptibility of these pathogens by the disc diffusion method. Results: A total of 588 bacterial isolates were identified from 476 episodes of bloodstream infections in cancer patients. Major pathogens were Escherichia coli (22.4%), Klebsiella pneumoniae (17.6%), and Pseudomonas aeruginosa (14.1%) in neutropenic patients and E coli (13.3%), K pneumoniae (10.1%), and Staphylococcus aureus (9.7%) in nonneutropenic patients. Of S aureus, 55.8% were resistant to methicillin, and of coagulase-negative Staphylococcus 87.0%. Cefepime, cefpirome, piperacillin/tazobactam, meropenem, or imipenem in combination with or without an aminoglycoside, were active against more than 85% of gram-negative bacilli (GNB). Ceftazidime, piperacillin, or ciprofloxacin plus an aminoglycoside were also active against more than 85% of GNB. The susceptibility rate of GNB or gram-positive cocci to any agent was not different between the isolates from neutropenic and nonneutropenic patients, but more GNB isolates from the former were susceptible to imipenem or meropenem plus an aminoglycoside. Conclusion: GNB remained dominant among bacteremic isolates in cancer patients. Antimicrobial agents, especially aminoglycoside-containing combination regimens, as recommended by Infectious Diseases Society of Taiwan for febrile neutropenia, were active against more than 85% of GNB isolates.
Date:	2011-10
Relation:	Journal of Microbiology, Immunology and Infection. 2011 Oct;44(5):376-381.
Link to:	http://dx.doi.org/10.1016/j.jmii.2011.01.035
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1684-1182&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000296662200010
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80053620310
Appears in Collections:	[Chi-Jung Wu] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP79951943549.pdf		156Kb	Adobe PDF	385	View/Open

Loading...